This pilot study is investigating expert perspectives on the social factors that influence the adoption and use of pre-exposure prophylaxis (PrEP), and its uptake in locations with disparities of access, awareness and infrastructure.
The Annual Report of Trends in Behaviour (ARTB) presents data from a selection of our behavioural and social research, focusing in particular on studies assessing trends over time or addressing emerging issues.
Pre-exposure prophylaxis (PrEP) was subsidised by the Australian Pharmaceutical Benefits Scheme (PBS) in April 2018. GPs and HIV/sexual health specialists are key actors to prescribing PrEP to get maximal coverage of populations at risk of acquiring HIV, particularly gay and bisexual men.
People living with long-term infections such as viral hepatitis or HIV face unique challenges as they age. Treatment side effects may hasten the ageing process, and/or predispose people to other medical issues.
During the last decade or so, the increasing popularity of the internet as a way to meet sex partners coincided with an increase in sexual risk-taking and HIV incidence among men who have sex with men (MSM).
This project involved undertaking the initial preparatory logistical and methodological development work to determine the feasibility of establishing an internet-based cohort and repeat cross-sectional research program among homosexually active men in Australia.
Attitudes of the HIV workforce to emerging HIV prevention technologies
This survey examines the attitudes of clinicians, policy makers, activists and health promotion workers to classic, community initiated, emerging and promising HIV biomedical prevention technologies: condom use, sero
The aim of this study was to test (1) the feasibility and effectiveness of respondent-driven sampling (RDS) for further implementation in the prospective studies in Australia; (2) the representativeness of the RDS sample, and (3) the new data collection instrument.
It is frequently assumed that biomedical technologies designed to treat and prevent disease, if given equitable access, will have uniform or predictable effects irrespective of the local context in which they are used or consumed.